Clinical Pharmacokinetic and Pharmacodynamic Profile of Idelalisib.

Clinical Pharmacokinetic and Pharmacodynamic Profile of Idelalisib.

Item
http://www.wikidata.org/entity/Q38560740
Idelalisib in the management of lymphoma.Idelalisib for the treatment of non-Hodgkin lymphoma.Pharmacokinetic drug-drug interactions of tyrosine kinase inhibitors: A focus on cytochrome P450, transporters, and acid suppression therapy.Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Chronic Lymphocytic Leukemia: Ibrutinib, Idelalisib, and Venetoclax.Practical Recommendations for Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology.Evaluating the Disposition of a Mixed Aldehyde Oxidase/Cytochrome P450 Substrate in Rats with Attenuated P450 Activity.Pharmacological inhibition of p110δ subunit of PI3K confers protection against experimental leishmaniasis.A Dual-Administration Microtracer Technique to Characterize the Absorption, Distribution, Metabolism, and Excretion of [14 C]Seletalisib (UCB5857) in Healthy Subjects.Assessment of drug-drug interaction potential between ceritinib and proton pump inhibitors in healthy subjects and in patients with ALK-positive non-small cell lung cancer.Idelalisib impairs TREM-1 mediated neutrophil inflammatory responses.
P2860

Clinical Pharmacokinetic and Pharmacodynamic Profile of Idelalisib.

Item
http://www.wikidata.org/entity/Q38560740
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Clinical Pharmacokinetic and Pharmacodynamic Profile of Idelalisib.
@en
type
label
Clinical Pharmacokinetic and Pharmacodynamic Profile of Idelalisib.
@en
prefLabel
Clinical Pharmacokinetic and Pharmacodynamic Profile of Idelalisib.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P356
P1433
P1476
Clinical Pharmacokinetic and Pharmacodynamic Profile of Idelalisib.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698